Intuitive Surgical, Inc. (ISRG)

US — Healthcare Sector
Peers: RGEN  RMD  MMSI  ICUI  BNGO  LUCY  STXS  NXGL  EMBC  BAX  WST  COO  TFX  BDX  HOLX 

Automate Your Wheel Strategy on ISRG

With Tiblio's Option Bot, you can configure your own wheel strategy including ISRG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

Jobless Claims Come in Slightly Higher
ABT, COF, FCX, GDP, GE, INTC, ISRG, PG
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Negative

Jobless Claims Come in Slightly Higher.

Read More
image for news Jobless Claims Come in Slightly Higher
Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%
ABT, COF, FCX, GDP, GE, INTC, ISRG, PG
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive

Weekly Jobless Claims continue to portray a labor market cruising along at a healthy low rate of unemployment claims.

Read More
image for news Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%
ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?
ISRG, MDT
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Neutral

Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.

Read More
image for news ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?
Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?
ISRG
Published: January 20, 2026 by: Zacks Investment Research
Sentiment: Negative

ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.

Read More
image for news Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?
2 Healthcare Names That Could Get a Big Boost From Earnings
ABT, ISRG
Published: January 20, 2026 by: MarketBeat
Sentiment: Positive

Active traders expect companies in the healthcare sector to experience significant share price spikes tied to milestones in the development of new therapies and medical products. The volatility in some corners of the sector makes it a high-risk, but high-reward, opportunity.

Read More
image for news 2 Healthcare Names That Could Get a Big Boost From Earnings
Is PODD A Better Bet Than ISRG Stock?
ISRG, PODD
Published: January 19, 2026 by: Forbes
Sentiment: Neutral

PODD is Intuitive Surgical's counterpart in the Health Care Equipment sector that has:

Read More
image for news Is PODD A Better Bet Than ISRG Stock?
AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
ISRG
Published: January 19, 2026 by: Zacks Investment Research
Sentiment: Positive

Intuitive Surgical is positioning da Vinci 5 as a data-driven platform, using AI, software and surgical data to expand beyond robotics into insights.

Read More
image for news AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
ISRG
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Negative

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.

Read More
image for news Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
ISRG
Published: January 16, 2026 by: Seeking Alpha
Sentiment: Positive

Intuitive Surgical continues robust double-digit growth, with Q4 2025 revenues up 19% y/y and strong da Vinci 5 adoption. The firm's 2026 procedure growth guidance of 13–15% disappointed versus expectations, triggering a recent share sell-off despite operational strength. Elevated multiples reflect the company's market dominance, but tactical buying on dips remains warranted for long-term growth investors.

Read More
image for news Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
ISRG
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Neutral

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Read More
image for news Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ISRG
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Neutral

Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Read More
image for news Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ISRG
Published: January 14, 2026 by: Seeking Alpha
Sentiment: Neutral

Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Read More
image for news Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
ISRG
Published: January 14, 2026 by: GlobeNewsWire
Sentiment: Neutral

SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.

Read More
image for news Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?
ISRG
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive

ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.

Read More
image for news Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?
Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance
ISRG
Published: January 09, 2026 by: Seeking Alpha
Sentiment: Positive

Intuitive Surgical, Inc. dominates surgical robotics with an 80% global share and a robust, recurring-revenue business model anchored by the da Vinci platform. ISRG's installed base and procedure volumes continue double-digit growth, driven by superior clinical outcomes and high hospital switching costs. Despite premium valuation (forward P/E ~64), ISRG's pristine balance sheet, strong margins, and relentless innovation justify a long-term Buy rating.

Read More
image for news Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
ISRG
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read More
image for news Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
ISRG
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive

ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.

Read More
image for news ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
Top Robotics Stocks That Could Drive Impressive Returns in 2026
CDNS, ISRG, NVDA, PATH
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive

Robotics is poised for steady growth in 2026. Consider PATH, NVDA, CDNS and ISRG for potential market dominance across sectors.

Read More
image for news Top Robotics Stocks That Could Drive Impressive Returns in 2026
ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
ISRG
Published: December 31, 2025 by: Zacks Investment Research
Sentiment: Positive

ISRG's single-port platform posts 91% procedure growth, led by Korea, with U.S. momentum building as new tools and indications expand adoption.

Read More
image for news ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?
ISRG, SYK
Published: December 24, 2025 by: Zacks Investment Research
Sentiment: Positive

Intuitive Surgical's robotics-first model, recurring revenue base, and margin leverage differentiate it from Stryker in terms of upside potential today.

Read More
image for news Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside?
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
ISRG
Published: December 23, 2025 by: Zacks Investment Research
Sentiment: Positive

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Read More
image for news Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
CAH, EW, ISRG, MDT
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive

Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.

Read More
image for news 4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts
ISRG
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Neutral

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $572.47, indicating a +1.88% shift from the previous trading day.

Read More
image for news Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts
Will Direct Distribution in Southern Europe Boost ISRG's Margins?
ISRG
Published: December 18, 2025 by: Zacks Investment Research
Sentiment: Positive

ISRG plans a 2026 shift to direct distribution in Italy, Spain, and Portugal, aiming to lift margins by capturing distributor economics with execution risk.

Read More
image for news Will Direct Distribution in Southern Europe Boost ISRG's Margins?
Is Most-Watched Stock Intuitive Surgical, Inc. (ISRG) Worth Betting on Now?
ISRG
Published: December 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read More
image for news Is Most-Watched Stock Intuitive Surgical, Inc. (ISRG) Worth Betting on Now?
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
ISRG
Published: December 11, 2025 by: Zacks Investment Research
Sentiment: Positive

Intuitive Surgical broadens its da Vinci SP system with FDA clearance for three new surgeries, expanding its role in minimally invasive care.

Read More
image for news ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
Can Intuitive Surgical Weather GLP-1 Drag on Bariatric Surgery?
ISRG
Published: December 11, 2025 by: Zacks Investment Research
Sentiment: Negative

Intuitive Surgical grapples with a GLP-1-driven bariatric slump but leans on strong general surgery gains and rising da Vinci 5 adoption.

Read More
image for news Can Intuitive Surgical Weather GLP-1 Drag on Bariatric Surgery?
ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?
ISRG
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Positive

Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.

Read More
image for news ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?
Intuitive Surgical: Is The Smart Money Moving In?
ISRG
Published: December 05, 2025 by: Forbes
Sentiment: Positive

Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted price.

Read More
image for news Intuitive Surgical: Is The Smart Money Moving In?
Is It Time To Buy Intuitive Surgical Stock?
ISRG
Published: December 05, 2025 by: Forbes
Sentiment: Positive

Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted price.

Read More
image for news Is It Time To Buy Intuitive Surgical Stock?

About Intuitive Surgical, Inc. (ISRG)

  • IPO Date 2000-06-16
  • Website https://www.intuitive.com
  • Industry Medical - Instruments & Supplies
  • CEO David J. Rosa
  • Employees 15638

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.